Collectively, data from western blot and immunofluorescence implied that pSTAT3 was negatively regulated by SHP2 in CRC cells, which might be a function different from that in other carcinomas such as leukemia20,21 and breast cancer22,23. This evidence concerns the gene PTPN11 and carcinoma.